新长安糖尿病
Published by:
Beijing Zhangmen Infinite Technology Co
Description
无论是糖尿病、高血压、肥胖症还是其他代谢性疾病，我们都能提供专业指导和支持，帮助您重获健康生活。选择我们，就是选择了一条更健康、更有活力的生活之路。立即预约，开始您的健康转变之旅！
Screenshots
新长安糖尿病 FAQ
-
Is 新长安糖尿病 free?
Yes, 新长安糖尿病 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 新长安糖尿病 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 新长安糖尿病 cost?
新长安糖尿病 is free.
-
What is 新长安糖尿病 revenue?
To get estimated revenue of 新长安糖尿病 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Brunei yet.
Ratings History
新长安糖尿病 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
长安内慢病门诊 Installs
Last 30 days
长安内慢病门诊 Revenue
Last 30 days新长安糖尿病 Revenue and Downloads
Gain valuable insights into 长安内慢病门诊 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Beijing Zhangmen Infinite Technology Co
- Languages
- English
- Recent release
- 1.0.8 (1 week ago )
- Released on
- Dec 12, 2024 (3 months ago )
- Also available in
- Lebanon, Uzbekistan, United States, Türkiye, Tunisia, Slovakia, Slovenia, Saudi Arabia, Romania, Portugal, Pakistan, Norway, Mexico, Malta, North Macedonia, Sri Lanka, Armenia, Kazakhstan, Japan, Italy, Iceland, Indonesia, Croatia, Egypt, Estonia, Dominican Republic, Colombia, Brunei, Bulgaria, Azerbaijan, Australia
- Last Updated
- 2 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.